These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12538066)

  • 1. A theoretical study of chemical delivery within the lung using exogenous surfactant.
    Zhang YL; Matar OK; Craster RV
    Med Eng Phys; 2003 Mar; 25(2):115-32. PubMed ID: 12538066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rapid bolus instillation with simplified slow administration of surfactant in lung lavaged rats.
    Fernández-Ruanova MB; Alvarez FJ; Gastiasoro E; Arnaiz A; Robertson B; Curstedt T; Valls-i-Soler A
    Pediatr Pulmonol; 1998 Aug; 26(2):129-34. PubMed ID: 9727765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?
    Joshi N
    Ther Deliv; 2018 Mar; 9(4):233-236. PubMed ID: 29495926
    [No Abstract]   [Full Text] [Related]  

  • 4. Barrier or carrier? Pulmonary surfactant and drug delivery.
    Hidalgo A; Cruz A; Pérez-Gil J
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):117-27. PubMed ID: 25709061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bolus dispersal through the lungs in surfactant replacement therapy.
    Espinosa FF; Kamm RD
    J Appl Physiol (1985); 1999 Jan; 86(1):391-410. PubMed ID: 9887154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique.
    Segerer H; van Gelder W; Angenent FW; van Woerkens LJ; Curstedt T; Obladen M; Lachmann B
    Pediatr Res; 1993 Oct; 34(4):490-4. PubMed ID: 8255683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury.
    Gilliard N; Richman PM; Merritt TA; Spragg RG
    Am Rev Respir Dis; 1990 Mar; 141(3):743-7. PubMed ID: 2310102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The wet bridge transfer system: a novel tool to assess exogenous surfactant as a vehicle for intrapulmonary drug delivery.
    Baer B; Veldhuizen EJA; Possmayer F; Yamashita C; Veldhuizen R
    Discov Med; 2018 Nov; 26(144):207-218. PubMed ID: 30695680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term distribution kinetics of intratracheally administered exogenous lung surfactant.
    Davis JM; Russ GA; Metlay L; Dickerson B; Greenspan BS
    Pediatr Res; 1992 May; 31(5):445-50. PubMed ID: 1603621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratracheal administration of glucocorticoids using surfactant as a vehicle.
    Nimmo AJ; Carstairs JR; Patole SK; Whitehall J; Davidson K; Vink R
    Clin Exp Pharmacol Physiol; 2002 Aug; 29(8):661-5. PubMed ID: 12099996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits.
    Broadbent R; Fok TF; Dolovich M; Watts J; Coates G; Bowen B; Kirpalani H
    Arch Dis Child Fetal Neonatal Ed; 1995 Mar; 72(2):F84-9. PubMed ID: 7712279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing efficacy of exogenous surfactant in acute lung injury.
    Lewis JF; Veldhuizen RA
    Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.
    Murgia X; Gastiasoro E; Mielgo V; Alvarez-Diaz F; Lafuente H; Valls-i-Soler A; Gomez-Solaetxe MA; Larrabe JL; Rey-Santano C
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):81-7. PubMed ID: 21410324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous surfactant replacement: how to deliver it?
    Biban P; Chini L; Bonetti P; Sacco F; Zaglia F; Santuz P
    Acta Biomed; 2012; 83 Suppl 1():27-32. PubMed ID: 23029874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury.
    Balaraman V; Sood SL; Finn KC; Hashiro G; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1838-43. PubMed ID: 8665043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume.
    van der Bleek J; Plötz FB; van Overbeek FM; Heikamp A; Beekhuis H; Wildevuur RH; Okken A; Bambang Oetomo S
    Pediatr Res; 1993 Aug; 34(2):154-8. PubMed ID: 8233717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant.
    Matalon S; Holm BA; Notter RH
    J Appl Physiol (1985); 1987 Feb; 62(2):756-61. PubMed ID: 3558235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant nebulisation: lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits.
    Dijk PH; Heikamp A; Bambang Oetomo S
    Intensive Care Med; 1997 Oct; 23(10):1070-6. PubMed ID: 9407243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug aerosol deposition analysis for a four-generation lung airway model with hemispherical tumors.
    Kleinstreuer C; Zhang Z
    J Biomech Eng; 2003 Apr; 125(2):197-206. PubMed ID: 12751281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.